Pharmacist Opioid Dispensing Confidence in an Evolving Practice Landscape

Herndon, Christopher M.; Riley, Ashley M.; Gattas, Nicole M.; Tiemeier, Amy

doi:10.1080/15360288.2022.2102704

Cited by 1 publication

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A recent survey study also found that pharmacists desired greater access to patient health information like patient diagnosis, prior treatments, past medical history, and previous treatment trials with opioids [101]. Clinicians were also interested in inter-state data to monitor patients who cross state lines to obtain their prescriptions [62,83,102], even though there is currently a mechanism through which US states share PDMP data.…”

Section: Clinicians Desire Improvements To Pdmpsmentioning

confidence: 99%

Helpful, Unnecessary, or Harmful: A Systematic Review of the Effects of Prescription Drug Monitoring Program Use on Opioid Prescriptions

Smith,

Thornton,

Fenton

et al. 2023

Pharmacoepidemiology

View full text Add to dashboard Cite

Prescription drug misuse is a global problem, especially in the United States (US). Clinician involvement is necessary in this crisis, and prescription drug monitoring programs (PDMPs) are a recommended tool for the prevention, recognition, and management of prescription opioid misuse. However, because of the plethora of differences between different PDMPs, research on their effects is mixed. Yet, despite varied evidence, policy on PDMP use is trending stricter and more comprehensive. We aimed to identify patterns in the research to inform clinicians and policy. Through a systematic review of four literature databases (CINAHL, Cochrane Database, Embase, and Medline/OVID), we found 56 experimental and quasi-experimental studies published between 2016 and 2023 evaluating PDMP effects on clinician behavior. To address study heterogeneity, we categorized studies by type of intervention and study outcome. The review suggests that more comprehensive PDMP legislation is associated with decreases in the number of opioid prescriptions overall and the number of risky prescriptions prescribed or dispensed. However, this review shows that much is still unknown, encourages improvements to PDMPs and policies, and suggests further research.

show abstract